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Abstract
Adenovirus is an important respiratory pathogen. Adenovirus fiber from most serotypes co-opts the Coxsackie-Adenovirus
Receptor (CAR) to bind and enter cells. However, CAR is a cell adhesion molecule localized on the basolateral membrane of
polarized epithelia. Separation from the lumen of the airways by tight junctions renders airway epithelia resistant to inhaled
adenovirus infection. Although a role for CAR in viral spread and egress has been established, the mechanism of initial
respiratory infection remains controversial. CAR exists in several protein isoforms including two transmembrane isoforms
that differ only at the carboxy-terminus (CAREx7 and CAREx8). We found low-level expression of the CAREx8 isoform in well-
differentiated human airway epithelia. Surprisingly, in contrast to CAREx7, CAREx8 localizes to the apical membrane of
epithelia where it augments adenovirus infection. Interestingly, despite sharing a similar class of PDZ-binding domain with
CAREx7, CAREx8 differentially interacts with PICK1, PSD-95, and MAGI-1b. MAGI-1b appears to stoichiometrically regulate the
degradation of CAREx8 providing a potential mechanism for the apical localization of CAREx8 in airway epithelial. In summary,
apical localization of CAREx8 may be responsible for initiation of respiratory adenoviral infections and this localization
appears to be regulated by interactions with PDZ-domain containing proteins.
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Introduction
The Coxsackievirus and Adenovirus Receptor (CAR) plays a
vital role in cell adhesion and viral infection [1–3]. The
importance of CAR within epithelial junctions, where it behaves
as an adhesion protein interacting with and potentially modulating
the trafficking of key PDZ domain containing molecules, is
becoming evident [4–7]. In contrast, how adenovirus initiates
infection of the airway epithelium and whether CAR plays a role
in initial adenoviral attachment and infection, when it is
sequestered on the basolateral side of airway epithelia, remains
unclear [8].
Alternative splicing plays an important role in eukaryotes.
During pre-mRNA splicing, the spliceosome cleaves intron
sequences, and joins exons together, forming an mRNA.
Regulation of the spliceosome can result in alternative splicing
of mRNA, determining which exons are present or absent in
template mRNA. Alternative splicing not only regulates protein
expression, but also allows multiple proteins to be expressed from
the same gene resulting in significant proteomic diversity [9].
Alternatively spliced proteins may maintain similar activity,
differing only in localization or interactions, or may vary widely
in activity or regulation. It is estimated that alternative splicing
occurs in 70–80% of human genes, but is more common in
regulatory genes, and tissues with diverse cell types [10].
CAR is encoded by a highly conserved, alternatively spliced gene
with five described transcripts. Three alternative transcripts encode
CAR, lacking the transmembrane domain, yielding a soluble
extracellular domain (splicing between exons 4/7, 3/7, 2/7) [11].
In experimental murine models, soluble CAR is able to inhibit viral
infection but also results in toxicity [12–16]. Although the mechanism
of toxicity is unknown, soluble CAR may be predicted to alter CAR-
CAR interactions and thus epithelial cell adhesion [17].
Human CAR was first described by Bergelson et al as a 7 exon
protein [1]. In contrast with other species, mouse CAR (mCAR)
was initially cloned as a protein composed of 8 exons [18] and was
named mCAR1. The 7 exon mouse form was subsequently
identified and termed mCAR2. A detailed analysis of protein
expression and localization in mice has revealed differential tissue-
dependent expression and localization for the exon 7 and exon 8
isoforms [19,20]. This suggests that the interactions and
potentially the functional importance of these two isoforms may
be distinct. Furthermore, considering the emerging importance of
signal transduction originating from microdomains within the cell
membrane, these two isoforms would be predicted to differentially
regulate cellular biology.
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The splicing event to create the 8th exon form occurs within the 7th
exon. Thus, these two isoforms contain identical extracellular and
transmembrane domains, which predicts identical adenovirus
binding and serotype preference. The majority of the cytoplasmic
domain is identical except for the last 26 (CAREx7) or 13 (CAREx8)
amino acids. Although comprised of distinct sequences, the last 4
amino acids of both isoforms encode class I PSD95/DlgA/ZO-1
(PDZ) binding domain sequences (-X-(S/T)-X-F, where X = any
amino acid andF = any hydrophobic amino acid). Interacting PDZ-
domain-containing proteins for human CAREx7 include MAGI-1b,
PICK1, PSD-95, MUPP-1, LNX1, and ZO-1 [5–7,21]. Further-
more, murine CAREx7 and CAREx8 interact with LNX2 and this
interaction appears to be modulated by both the PDZ binding
domain of each isoform as well as an upstream sequence common to
both isoforms [22].
In contrast with the murine isoform, the protein for human CAREx8
has never been described. We used a computational approach to
identify human exon 8 encoding CAR, and investigated the functional
significance of this isoform in primary human airway epithelia.
Results
Human CAR exon 8 containing isoform
Mouse CAR was originally cloned as an 8 exon protein. We
hypothesized that human CAR may exist as an 8 exon protein as
well (Figure 1A). We first determined whether the human genome
contained homologous sequence for exon 8, by performing a BLAT
search against the mouse sequence (www.genome.ucsc.edu). Similar
sequences were identified for human, chimpanzee, dog and rat
(Figure 1B). The predicted amino acid sequence for human and
chimpanzee is identical. This sequence differs from mouse by one
amino acid. Comparison of hCAR P343 to mCAR A343 using
Conseq software identified this amino acid as an exposed or buried
residue respectively with a non-structural role. Conservation could
not be determined due to insufficient data. The score assigned by
Conseq was validated using PolyPhen (http://www.bork.embl-
heidelberg.de/polyPhen/), which assigns scores, derived from
likelihood matrices, as ‘‘benign’’, ‘‘possibly damaging’’, ‘‘probably
damaging’’, or ‘‘unknown’’. The change P343A was designated as
‘‘benign.’’ Although an intuitive difference between these two amino
acids exists, based on these analyses, additional studies to determine
whether protein function was affected were not pursued. Primers
were designed for RT-PCR to evaluate the presence of hCAREx8 in
several human cell lines including HeLa, 293, A549, Caco-2, and
primary human airway epithelia. Transcripts for both hCAREx7
and hCAREx8 were detected in all cell lines and primary cells
examined (data not shown). A panel of human RNA was
subsequently screened for the full-length hCAREx7 (Figure 1D) or
hCAREx8 (Figure 1E), and yielded full length as well as smaller
bands for both transcripts. Semi-quantitative analysis of the bands
for hCAREx7 suggested that heart.brain,lung.liver. In contrast,
hCAREx8 transcripts showed a rank order of liver,heart.
brain.lung. These data suggest that as in mice, human splice
variant expression varies between organs.
Localization and function of hCAREx8 is similar to hCAREx7
in non-polarized cells
COS-7 cells were transfected with the cDNA for hCAREx7
(Figure 2A) or hCAREx8 (Figure 2B). Immuno-localization using
the FLAG antibody showed a similar distribution for both with
predominant junctional staining in addition to some perinuclear
staining. CAR-negative CHO cells transiently expressing
hCAREx7, hCAREx8, or GFP were infected with recombinant
adenovirus containing the bacterial LacZ gene (Figure 2C). As
previously described, CHO cells and CHO cells expressing GFP
are refractory to adenovirus-mediated gene transfer [23]. In
contrast, cells expressing hCAREx7 or hCAREx8 showed robust
and similar levels of adenovirus-mediated gene transfer proving
that both forms of CAR function as adenoviral receptors.
Localization of hCAREx8 is distinct from hCAREx7 in
polarized cells
We hypothesized that hCAREx8 localization may differ from
hCAREx7 in polarized cells. Primary well-differentiated human
Figure 1. Human CAR is an 8 exon alternatively spliced protein. Panel A shows a schematic diagram of the published and predicted human
and mouse exon arrangement. Panel B shows the alignment of the mouse CAR exon 8 with the predicted exon 8 from other species. Panel C and D
show representative RT-PCR for human CAR Exon 8 or 7, respectively, in cells (HeLa) or tissues.
doi:10.1371/journal.pone.0009909.g001
Novel CAR Exon 8 Interactions
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airway epithelia, greater than two weeks of age, were stained for
endogenous hCAREx7 (Figure 2D, green), hCAREx8 (Figure 2E,
green) with antibodies raised to peptides composed of the last 13
amino acids of either hCAREx7 or hCAREx8, or pre-immune
serum control (Figure 2F, green), and were co-stained for the tight
junction protein ZO-1 (red). Distinct patterns of localization were
observed for these two isoforms. As previously shown, hCAREx7
localizes to the tight and adherens junctions of airway epithelia
[23]. In contrast, hCAREx8 localizes primarily to the upper region
of the cytoplasm and apical surface above ZO-1 (Figure 2E,
arrow), without ZO-1 tight junction overlap. In contrast to ZO-1,
co-localization was observed when co-stained with the apical
protein ezrin (Figure S1). To determine the relative abundance of
the two isoforms in polarized airway epithelia (in vitro) or lung
tissue (in vivo), RNA was extracted from human airway epithelia
greater than two weeks of age or total lung tissue, respectively, and
subjected to quantitative RT-PCR (see Figure S2 for primer
specificity). Despite donor variability, hCAREx8 levels were
consistently markedly lower than hCAREx7 both in cultures and
tissues (Figure 2G, Figure S2) with a similar ratio of hCAREx7 to
hCAREx8 both in vitro and in vivo (Figure 2H). To confirm the
distinct localization of these isoforms, airway epithelia, greater
than two weeks of age, were transduced from the basolateral side
with adenovirus containing the cDNA for hCAREx7 or hCAREx8,
and subjected to immunocytochemistry 36 hours later. Recombi-
nant expression levels are markedly higher than endogenous levels,
thus confocal microscopy settings are set at a level that does not
detect endogenous. Nevertheless, the localization of recombinant
hCAR was similar to that seen with endogenous isoforms.
Whereas the majority of hCAREx7 localized to the basolateral
membrane (Figure 2I), hCAREx8 was largely diffusely distributed
throughout the cell but was also present at the apical membrane
where it appeared above ZO-1 (Figure 2J), below the cilia, marked
by acetylated a-tubulin (Figure 2K), and overlapped at the same
Figure 2. Human CAREx8 localization and adenovirus-mediated gene transfer is similar to hCAREx7 in cell monolayers but distinct in
polarized cells. COS-7 cells transfected with hCAREx7 (A) or hCAREx8 (B) show a similar distribution. Panel C shows that CHO cells transfected with
hCAREx7 or hCAREx8 mediate similar adenovirus gene transfer. Immunocytochemistry for endogenous hCAREx7 (D) or hCAREx8 (E) (green) reveals
distinct localization in polarized primary human airway epithelia greater than 2 weeks of age. hCAREx7 localizes to the basolateral membrane and
shows co-localization with the basolateral portion of ZO-1 (red, D, E, F). hCAREx8 localizes diffusely in the upper region of the cytoplasm with some
apical staining (see arrowhead). Panel F shows ZO-1 (red) and a lack of staining with control rabbit pre-immune serum (green). Panel G shows the
abundance of CAREx7 or CAREx8 transcripts in primary cultures (in vitro) or from lung tissue (in vivo). Panel H shows that the relative enrichment of
CAREx7 to CAREx8 transcripts is similar in vitro and in vivo. Localization of hCAREx7 (I) or hCAREx8 (J, K, L, M) after over-expression in primary cultures and
co-stained (red) for ZO-1 (I, J), acetylated a-tubulin (K), CD55/decay accelerating factor (DAF, L), or ezrin (M). Panel N shows that expression of
exogenous hCAREx8 in polarized human airway epithelia mediates two-fold greater adenovirus gene transfer than hCAREx7 in comparison to control
GFP transduced cells. *p,0.01. Confocal microscopy (60x oil immersion).
doi:10.1371/journal.pone.0009909.g002
Novel CAR Exon 8 Interactions
PLoS ONE | www.plosone.org 3 March 2010 | Volume 5 | Issue 3 | e9909
level with apical membrane markers decay accelerating factor
(DAF, Figure 2L) and ezrin (Figure 2M) [24–26]. We hypothesized
that endogenous hCAREx8 may be responsible for the inefficient,
albeit detectable, level of adenovirus infection from the apical
surface of airway epithelia. To determine if augmenting expression
would augment adenovirus infection, dissociated airway epithelia
were transduced with hCAREx7, hCAREx8 or GFP and seeded on
semi-permeable filters. Cultures were allowed to polarize and form
an epithelium over 1 week. When the resistance of all cultures was
above 300 mVNcm22, cells were infected from the apical surface
with adenovirus containing the LacZ gene (Figure 2N). Human
airway epithelia expressing GFP showed baseline low level
adenovirus-mediated gene transfer. Epithelia expressing hCAREx8
showed approximately 5-fold greater gene transfer than epithelia
expressing GFP (Figure 2N) or mock transduced (Figure S3) and
close to a 100% increase in gene transfer compared to epithelia
expressing hCAREx7 (Figure 2N) This increase in infection is
similar to previously published results for glycophosphatidylinosi-
tol-linked hCAR which is missing the transmembrane and
cytoplasmic domains and localizes explicitly to the apical surface
of polarized airway epithelia [27]. This suggests that hCAREx8
explains the low-level baseline apical adenovirus infection and that
there may be a maximal amount of infection possible through
apically localized receptor. These data also raise the question why
hCAREx8 does not localize to the basolateral surface.
hCAREx8 interacts with PSD-95 but not PICK1 via the PDZ
binding domain
PDZ-interactions may modulate localization as well as function.
It is known that both the sequence of the binding domain and the
upstream sequences affect PDZ domain interactions. The
mechanism by which the upstream sequences affect the specificity
of interaction remains unclear. Although hCAREx7 and hCAREx8
have type 1 PDZ binding domains (X(S/T)XW) at the C-terminus
(hCAREx7 –GSIV; hCAREx8 –ITVV), these and the upstream
sequences are distinct. Thus we hypothesized that PDZ-interac-
tions may be responsible for altered localization in human airway
epithelia. We have previously shown that hCAREx7 interacts with
PICK1 and PSD-95 via a PDZ binding domain specific
interaction such that co-localization by immunocytochemistry
reveals hCAREx7 is able to pull these proteins out of the cytoplasm
and co-localize at the junctions between cells. We further
hypothesized that hCAREx8 may interact with some hCAREx7
partners. COS-7 cells were co-transfected with hCAREx8 and
PSD-95-GFP and immunocytochemistry was performed to
determine localization. hCAREx8 localized to the junctions as
observed in Figure 2B. In the absence of hCAREx8, PSD-95-GFP
localizes diffusely within the cytoplasm [6]. In the presence of
hCAREx8, the localization of PSD-95-GFP was altered to co-
localize with hCAREx8 at the junctions of cells (Figure 3A).
Localization of a PDZ mutant form of hCAREx8 (hCAREx8-PDZ)
was similar to full length hCAREx8 (Figure 3B) and was unable to
alter the diffuse localization of PSD-95-GFP upon co-transfection.
Whereas an interaction with full length hCAREx8 was evident by
co-immunoprecipitation (Figure 3C), no interaction was observed
by coimmunoprecipitation with hCAREx8-PDZ, indicating that this
interaction requires the ITVV PDZ binding domain sequence.
Next, hCAREx8 and PICK1-GFP were co-transfected into COS-7
cells. Immunocytochemistry for hCAREx8 revealed the lack of
interaction between PICK1-GFP and CAREx8 at the junctions
where the majority of hCAREx8 was localized (Figure 3D). In some
cells there was co-localization in the perinuclear region. To
determine if there was a physical interaction, each protein was
immunoprecipitated and evaluated by Western blot (Figure 3E).
No interaction was detected. Taken together, these data suggest
that either there is no interaction or the interaction is too weak to
Figure 3. hCAREx8 co-localizes and interacts with PSD-95 but not PICK1. Panel A shows co-localization (yellow) of hCAREx8 (red) and PSD-95-
GFP (green). In contrast, in panel B, hCAREx8-PDZ does not co-localize at the junctions of cells. hCAREx8-PDZ localizes to the junctions between cells
whereas PSD-95-GFP fluorescence remains diffuse. Panel C shows immunoprecipitation of PSD-95-GFP with the hCAR specific extracellular domain
monoclonal antibody RmcB, GFP antibody, but not a control antibody (MopC). Panels D and E shows the lack of co-localization and
immunoprecipitation between hCAREx8 (junctional) and PICK1-GFP (perinuclear). Confocal microscopy (60x oil immersion).
doi:10.1371/journal.pone.0009909.g003
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pull PICK1-GFP to the intercellular junctions. Co-localization of
hCAREx8 and PICK1-GFP in the perinuclear region may
represent an artifact of high protein expression or alternatively
PICK1-related retention of CAREx8.
hCAREx8 interaction with MAGI-1b-GFP results in hCAREx8
degradation
hCAREx8 differentially interacts with hCAREx7 PDZ-mediated
interacting partners despite having a similar class of PDZ binding
domain. We have previously shown an interaction between
hCAREx7 and MAGI-1b-GFP (Figure 4A-C). To investigate the
interaction between hCAREx8 and MAGI-1b-GFP, COS-7 cells
were co-transfected and evaluated by immunocytochemistry.
Surprisingly, little to no hCAREx8 staining (Figure 4D) was present
in cells expressing MAGI-1b-GFP (Figure 4E). Most of the small
amount of hCAREx8 present within MAGI-1b-GFP positive cells
appeared within vesicular structures and not the junctions
(Figure 4F). The presence, localization and amount of hCAREx8
appeared to be dependent on the amount of MAGI-1b-GFP. A
small percentage of cells appeared to express hCAREx8 alone and
the expression was robust in comparison to neighboring MAGI-
1b-GFP expressing cells (Figure 4G-I).This was not the case for
Figure 4. Co-expression of hCAREx8 and MAGI-1b-GFP results in the loss of hCAREx8. In contrast to the co-localization of hCAREx7 (A, red)
and MAGI-1b-GFP (B, green) as shown in panel C (yellow), co-expression of hCAREx8 (D, G, red) and MAGI-1b-GFP (E, H, green) results in decreased
levels of hCAREx8 (F) unless MAGI-1b-GFP is absent from the cell (I). Co-expression of hCAREx8 (J, red) with GFP (K, green) results in abundant hCAREx8
expression at the junctions of the cells and diffuse GFP expression (L). Confocal microscopy (60x oil immersion).
doi:10.1371/journal.pone.0009909.g004
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PSD-95-GFP, PICK1-GFP, or GFP (Figure 4G-I). hCAREx8 was
detectable by Western blot, presumably due to the relatively few
cells transfected with hCAREx8 but not MAGI-1b-GFP. No
interaction between hCAREx8 and MAGI-1b-GFP was observed
by co-immunoprecipitation even when cells were treated with
proteosomal inhibitors (data not shown). These data suggest that a
transient interaction between MAGI-1b and hCAREx8 results in
the disappearance of hCAREx8.
Quantitation of the stoichiometric hCAREx8 interaction
with MAGI-1b-GFP
Since some MAGI-1b-GFP expressing cells also expressed
some, albeit mislocalized, hCAREx8, we hypothesized that
there would be a stoichiometric relationship between these
proteins. COS-7 cells were electroporated with a dose response
of hCAREx8 (0-30 mg plasmid DNA) in the presence of constant
(15 mg plasmid) MAGI-1b-GFP or GFP. hCAREx8 expression
was evaluated by immunocytochemistry (red fluorescence)
using fluorescence microscopy and Western blot. Fluorescence
intensity was calculated as average pixel count per field of view
(n = 6, Figure 5A). Increasing the amount of hCAREx8 plasmid,
in the presence of constant GFP plasmid, resulted in a
relatively linear increase in hCAR fluorescence (Figure 5A).
In contrast, when hCAREx8 was co-transfected with a constant
amount of MAGI-1b-GFP, the dose response curve was shifted
significantly to the right, indicating that hCAREx8 expression
was suppressed in the presence of MAGI-1b-GFP relative to
co-expression with GFP. Western blot using the hCAREx8
specific antibody was quantitated by chemiluminescence
imaging, relative to b-actin protein expression (Figure 5B),
and revealed a similar relationship. Although a rapid increase
in hCAREx8 protein in the presence of GFP was observed, the
sensitivity of detection was apparent by the plateau of the
curve. The dose response curve for hCAREx8, when co-
transfected with MAGI-1b-GFP, was again shifted significantly
to the right. The observed difference in hCAREx8 protein was
not due to transfection or transcription since quantitative PCR
for plasmid and RT-PCR for hCAREx8 RNA were similar (data
not shown). Moreover, no effect was observed on GFP or
MAGI-1b-GFP fluorescence upon increasing hCAREx8 (data
not shown).
MAGI-1b-GFP interaction with CAREx8 decreases
adenovirus infection
To determine a physiological response to the loss of hCAREx8 in
the presence of MAGI-1b-GFP, CHO-K1 cells were transfected
with hCAREx8 or MAGI-1b-GFP, or co-transfected with
hCAREx8, at a constant dose, with MAGI-1b-GFP at increasing
doses. All transfections were balanced with GFP plasmid to
maintain equal amounts of DNA. Transfected cells were
transduced with Ad-b-gal 48h later. b-galactosidase expression
was determined 24 hr post-transduction (Figure 5C). Similar to
Figure 2C, transfection of CHO-K1 cells with hCAREx8 renders
them susceptible to adenovirus infection while transfection with
MAGI-1b-GFP does not. Co-transfection of hCAREx8 with a dose
response of MAGI-1b-GFP resulted in a dose-related reduction of
susceptibility to Ad-bgal-mediated gene expression, indicating that
there was a reduction of cell surface hCAREx8 available as a
receptor. Taken together with the previous data, we concluded
that in contrast to hCAREx7, co-expression of hCAREx8 with
MAGI-1b-GFP results in the disappearance of hCAREx8 and may
explain the absence of hCAREx8 in the adherens junctions of
airway epithelia.
The hCAREx8-MAGI-1b-GFP interaction requires the
hCAREx8 PDZ binding domain
The interaction between the hCAREx7 isoform with MAGI-1b-
GFP requires the CAREx7 PDZ binding domain (-GSIV). To
determine the requirement of the hCAREx8 PDZ binding domain,
a stop codon was added to the cDNA of hCAREx8 by site-directed
Figure 5. Co-expression of hCAREx8 with MAGI-1b-GFP results in
less immunofluorescence, protein, and adenovirus-mediated
gene transfer. COS-7 cells were transfected with 0 to 30 mg of hCAREx8
+/2 15 mg MAGI-1b-GFP and evaluated for hCAREx8 specific immuno-
fluorescence (A) or CAREx8 specific protein by Western blot (B). In the
presence of MAGI-1b-GFP, the hCAREx8 expression curve is shifted to
the right suggesting a loss of hCAREx8 protein. Panel C shows CHO cells
transfected with varying amounts of hCAREx8 and MAGI-1b-GFP, and
evaluated for Ad-b-galactosidase gene transfer. Co-expression of MAGI-
1b-GFP resulted in a decrease of adenovirus-mediated gene transfer in
a dose response relationship. *p,0.03.
doi:10.1371/journal.pone.0009909.g005
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mutagenesis resulting in a protein missing the last 4 amino acids
(-ITVV). Similar to wild-type hCAREx8 (Figure 2B), COS-7 cells
transfected with hCAREx8-PDZ showed robust junctional localiza-
tion with some protein within intracellular vesicles (Figure 6A).
Co-transfection of hCAREx8-PDZ with MAGI-1b-GFP resulted in
co-expression of both proteins and did not alter the junctional
localization of hCAREx8-PDZ (Figure 6B) or show diffuse
localization of MAGI-1b-GFP (Figure 6C). These data indicate
that the PDZ binding domain is required for the disappearance of
hCAREx8. Thus, an interaction between hCAREx8 and MAGI-1b
is required, raising the question of how this interaction differs from
hCAREx7 and MAGI-1b.
The upstream sequence plays a role in PDZ interactions
We have previously shown a PDZ dependent interaction between
hCAREx7 and PICK1-GFP [6]. Figure 3D demonstrates that there
is no co-localization, and Figure 3E, shows there is no co-
immunoprecipitation when hCAREx8 and PICK1-GFP are co-
expressed. hCAREx7 and hCAREx8 differ by only the terminal 26 or
13 amino acids respectively. Since both hCAREx7 and hCAREx8
have type I PDZ binding domains we asked whether the PICK1
interaction was dependent on the terminal 4 amino acid sequence
or the unique upstream sequences. To further define the role these
sequences play in the PDZ domain-PDZ binding domain
interaction, the hCAREx7 PDZ binding domain was swapped with
the hCAREx8 PDZ binding domain (i.e. 22aa of hCAREx7 followed
by ITVV, hCAREx7/8) or the hCAREx8 was swapped with
hCAREx7 (i.e. 9aa of hCAREx8 followed by GSIV, hCAREx8/7).
hCAREx7, hCAREx8, hCAREx7/8, or hCAREx8/7 were each co-
transfected with PICK1-GFP. As previously shown, co-transfection
of COS-7 cells with hCAREx7 and PICK1-GFP results in
accumulation of hCAREx7 at the junctions of cells (Figure 7A)
and hCAREx7 is able to pull PICK1-GFP (Figure 7B) from a
perinuclear localization to the junctions of cells (Figure 7C). In
contrast, as also demonstrated in Figure 3D, co-transfection of
COS-7 cells with hCAREx8 and PICK1-GFP results in accumula-
tion of hCAREx8 at the junctions of cells (Figure 7D). However,
PICK1-GFP (Figure 7E) remains in a perinuclear localization
(Figure 7F). Transfection of either hCAREx7/8 (Figure 7G) or
hCAREx8/7 (Figure 7H) alone resulted in junctional localization.
Interestingly, co-transfection of COS-7 cells with hCAREx7/8 and
PICK1-GFP results in the co-localization of hCAREx7/8 (Figure 7I)
and PICK1-GFP (Figure 7J) at the junctions of cells (Figure 7K).
This suggests that the sequence ITVV is able to interact with
PICK1-GFP but not in the context of the upstream hCAREx8
unique sequence. Finally, co-transfection of COS-7 cells with
hCAREx8/7 and PICK1-GFP results in accumulation of hCAREx8/7
at the junctions of cells (Figure 8L), while PICK1-GFP (Figure 8M)
remains in a perinuclear localization in a manner similar to wild
type hCAREx8 (Figure 8N). These data indicate that the upstream
sequence plays a significant role in the specificity of the PDZ
domain-PDZ binding domain interaction and thus interactions
must be defined experimentally.
hCAREx8 PDZ binding domain and upstream nine amino
acids define the MAGI-1 interaction
The above data indicates that sequence immediately upstream
of the PDZ binding domain may define the PDZ interaction. The
difference between the respective interactions of hCAREx7 or
hCAREx8 with MAGI-1b-GFP may also be due to interactions
with the upstream 22 or 9 amino acids, the 4 terminal PDZ
binding domain amino acids or a combination of both. Co-
transfection of hCAREx7/8 with MAGI-1b-GFP resulted in the
relocation and co-localization of MAGI-1b-GFP with hCAREx7/8
at the junctions of cells (Figure 8A-C). Interestingly, co-
transfection of hCAREx8/7 with MAGI-1b-GFP revealed an
intermediate phenotype (Figure 8D-F). Although there were
depressed levels of hCAREx8/7 within the population of transfected
cells (Figure 8D), some cells showed low levels of hCAREx8/7
expression at the junctions and low levels of co-localization with
MAGI-1b-GFP at these junctions. Taken together with the results
in Figure 7, these data suggest that although the PDZ binding
domain is required for the interaction, both the exact sequence of
the binding domain and upstream sequences may modulate the
interactions of PDZ domain containing proteins.
Discussion
Adenoviruses are among the most studied viruses from the viral
biology, cell biology and pathogenesis perspective. However, the
failure of these viruses in applications for airway gene therapy and
the identification of a basolaterally localized receptor, hCAR,
made it clear that apical infection is inefficient. We and others
found that once an epithelial cell is infected, progeny viruses can
easily infect neighboring cells via the basolateral route, and
moreover, disruption of cell adhesion by fiber allows virus escape
into the lumen of the airway and back into the environment [4].
The question remained: is the initial infection random, requiring
damage or does it use the adenovirus fiber-knob or another
receptor?
Human transcripts containing the predicted exon 8 have been
described [2,28] but protein presence never verified. To better
Figure 6. MAGI-1b-GFP-mediated loss of hCAREx8 requires the PDZ-binding domain (ITVV) of hCAREx8. COS-7 cells were transfected
with hCAREx8-PDZ (A, red) or co-transfected with hCAREx8-PDZ (B, red) and MAGI-1b-GFP (C, green). Panel D shows the lack of co-localization of hCAREx8-PDZ
(junctions) and MAGI-1b-GFP (cytoplasmic/diffuse). Confocal microscopy (60x oil immersion).
doi:10.1371/journal.pone.0009909.g006
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understand the function of hCAR we sought to investigate the
presence, localization and interactions of human CAREx8 and
their relevance in the human airway epithelium.
Proteins exhibit regulation at multiple levels. Here we show that
not only is the transmembrane form of human CAR regulated by
splicing, but also the exon 8 specific isoform is subsequently
regulated at the protein level by the PDZ domain containing
protein MAGI-1b. Furthermore, hCAREx8 localizes to the apical
compartment of human airway epithelia where it could serve as
the receptor initiating adenovirus infection.
RNA splicing is an important event that significantly increases
proteomic diversity and may impart cell specificity. Despite the
importance of hCAR in viral infection, cell adhesion, and
development, the genetic and splicing regulation of the gene for
hCAR, CXADR, have not been well studied. It is known that
expression of hCAR is upregulated by histone deacetylase (HDAC)
inhibitors, a finding with significant implications for oncolytic
adenoviral cancer therapy [29–31]. Whether HDAC inhibitors
affect the splicing of hCAR is also currently unknown.
Several transcripts have been described for hCAR. However,
the importance of each splice variant is unclear. Secreted splice
variants that interact with the extracellular domain of the
transmembrane form of hCAR could clearly alter homophilic
transmembrane hCAR interactions and hence modulate junction-
al remodeling. These variants could also play a physiological role
modulating interactions between hCAR and its ligand, AMICA1/
JAML, found on transmigrating lymphocytes and dendritic cells
[32].
Considering the importance of junctional organization, inter-
actions, and signaling, alternative transmembrane forms could
play equally important roles in junctional remodeling and
responses to ligation with soluble isoforms or ligands on other
cell types. Two transmembrane isoforms are known for CAR.
Although several interactions have been discovered for both the
mouse and human CAREx7 isoform, only one interaction has been
described for the alternative, less prevalent mouse CAREx8
isoform. Both mouse CAREx7 and CAREx8 interact with Ligand-
of-Numb Protein-X2 (LNX2), an intracellular scaffolding protein
that may play a role in Notch signaling [22]. Interestingly, both
isoforms interact with LNX2 through two different regions within
the intracellular domain of mCAR; each unique C-terminal PDZ
binding domain and a region in common just upstream of the
splice junction.
Our previous work revealed that interaction with hCAREx7
results in junctional localization of MAGI-1b [6]. In contrast, this
work shows that the interaction with hCAREx8 is unique to other
MAGI-1b interactions since it results in the loss of hCAREx8.
Epithelia express MAGI-1b where it localizes to the basolateral
junctions. hCAREx7 also localizes to the basolateral junctional
adhesion complex. The data presented herein is consistent with
Figure 7. The result of the MAGI-1b-GFP interaction with hCAR requires both the PDZ binding domain and the upstream isoform
specific amino acids. The PDZ binding domain of hCAREx7 and hCAREx8 were swapped by PCR as shown in panel A. Both constructs contained
identical upstream sequences. The localization was determined in transfected COS-7 cells either alone, hCAREx7/8 (B), hCAREx8/7 (C) or upon co-
transfection with MAGI-1b-GFP (D-I). Panels D and E show junctional expression of hCAREx7/8 and MAGI-1b-GFP, respectively, and co-localization in
panel F. Panel G shows minor expression of hCAREx8/7 in the presence of robust MAGI-1b-GFP expression in panel H. Some co-localization is observed
in panel I. Confocal microscopy (60x oil immersion).
doi:10.1371/journal.pone.0009909.g007
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MAGI-1b interacting with hCAREx7 at the junctions between
epithelial cells. It is also consistent with the unexpected apical
localization of hCAREx8. If hCAREx8 were to go to the basolateral
junctions, it would be predicted to interact with MAGI-1b and be
degraded. Thus the only place it could exist in the cell is in an
apical compartment devoid of MAGI-1b. Alternatively, there may
be a specific mechanism for the apical localization of hCAREx8
that remains to be discovered. Apical localization is consistent with
elevated adenovirus infection after expression of hCAREx8. Thus
this isoform of hCAR would be able to interact with adenovirus on
the luminal air-exposed surface and mediate the initial infection of
an epithelium. It is notable that the increase of infection is similar
to the extracellular domain of hCAR conjugated to a glycopho-
sphatidyl-inositol (GPI) tail, which explicitly is apically localized in
Figure 8. The interaction between the hCAR PDZ binding domain and PICK1 depends on both the PDZ binding domain and the
upstream isoform specific amino acids. The PDZ binding domain of hCAREx7 and hCAREx8 were swapped by PCR as shown in Figure 7, panel A.
The localization was determined in transfected COS-7 cells. hCAREx7 (A) transfected with PICK1-GFP (B) results in co-localization at the junctions (C,
yellow). hCAREx8 (D) transfected with PICK1-GFP (E) results in no co-localization at the junctions (F). hCAREx7/8 (G) transfected with PICK1-GFP (H)
results some co-localization at the junctions (I, yellow). hCAREx8/7 (J) transfected with PICK1-GFP (K) results in no co-localization at the junctions (L).
Confocal microscopy (60x oil immersion).
doi:10.1371/journal.pone.0009909.g008
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airway epithelia [27,33]. In vitro, the C-terminus of hCAR is not
required for adenovirus infection [27], however, considering the
distinct localization and interactions between these isoforms, we
cannot predict whether infection is identical in vivo. Furthermore, it
is interesting to speculate that mutations altering the splicing or
transcript abundance of the hCAREx8 isoform may be responsible
for viral susceptibility.
PDZ-based regulation has been described for other membrane
proteins [34,35]. For example several PDZ-domain containing
proteins are known to interact with the cystic fibrosis transmem-
brane conductance regulator (CFTR) [36,37]. In contrast to
hCAREx7, CFTR traffics to the apical membrane of airway
epithelia where it behaves as a chloride channel. Interactions
between the PDZ-binding domain of CFTR and the PDZ domain
of Na+/H+ exchanger-3 regulatory factors 1 and 2 (NHERF1 and
NHERF2) act to stabilize CFTR at the cell surface [38]. CFTR
PDZ interactions with the CFTR-associated ligand (CAL) target
CFTR for lysosomal degradation [39]. Cushing et al have recently
shown that the delicate balance of interactions regulating cell
surface maintenance and lysosomal degradation upon cycling is
due to the relative affinity of the PDZ interactions [37]. The
stronger interaction between CFTR and NHERF1/2 would be
predicted to out compete the weaker interaction with CAL
resulting in the relatively long CFTR half-life observed. This type
of regulation differs from our data in at least two ways. One
isoform (CAREx7) appears to be dominant in directing the
localization of the PDZ-domain containing proteins while
MAGI-1b is dominant in the interaction with hCAREx8 resulting
in the loss of this protein. To our knowledge, all descriptions of
PDZ-directed degradation have been during mature protein
cycling. In contrast, we have observed immediate loss of hCAREx8
implying regulation during early protein synthesis or quality
control stages.
The question remains why differential compartmentalization of
these hCAR isoforms would exist. The signals transduced by these
isoforms, despite having the same extracellular ligands, may differ.
Differential localization of these two isoforms could result in the
cell being able to discern whether the signal is from the apical or
basolateral compartment and mount the appropriate response. For
example, both isoforms would recognize AMICA1/JAML present
on the surface of neutrophils and dendritic cells. hCAREx7 may be
a gatekeeper for neutrophil transmigration but hCAREx8 may
either tether neutrophils to the apical surface or sense how many
neutrophils are present. Alternatively, these two isoforms may play
a role in dendritic cell surveillance and maintaining the seal
around dendritic cell filopodia.
These data also provide support for the importance of
sequences upstream of the PDZ binding domain in dictating
target PDZ domains and subsequent activity. Both the GSIV (Ex7)
and ITVV (Ex8) sequences bind all three targets investigated,
MAGI-1b, PICK1 and PSD95. However, the presence of the
upstream 9 unique amino acids from hCAREx8 alters the resulting
interaction such that PICK1 does not interact, PSD-95 does
interact to localize at cellular junctions, and MAGI-1b results in
degradation of the hCAREx8 protein. In contrast, the 22 amino
acids from hCAREx7 allow a stable interaction between these three
proteins and the ITVV PDZ-sequence from hCAREx8 resulting in
co-localization at the junctions of cells. The exact mechanism
requires further investigation and will lead to a greater
understanding of this important class of protein interaction
domains.
In summary, human airway epithelia express several isoforms of
hCAR. Importantly, human CAREx8 localizes to the apical surface
where it may play a key role in the initiation of adenoviral, and
potentially coxsackievirus, pulmonary infection. We propose a
model for the regulation of this localization based upon isoform-
specific PDZ binding domain interactions with MAGI-1b.
Although PDZ based interactions are known to be key regulators
of membrane microdomain structure, stability and signaling, we
have shown that this interaction may also regulate protein
expression. Furthermore, PDZ based interactions are influenced
by several factors, including PDZ binding domain and upstream
sequence context. Affinity of interaction between the PDZ domain
and PDZ binding domain may be higher or lower depending on
surrounding sequences resulting in the specificity of interaction.
Surprisingly, either interacting partner can be dominant in
dictating the result of the interaction (i.e. junctional trafficking
versus degradation). Further elucidation of these mechanisms may
provide a novel target for either down regulation of the adenovirus
receptor to limit viral infection or alternatively up regulation for
the purpose of adenoviral-based therapies.
Materials and Methods
Ethics statement
This study was conducted according to the principles expressed
in the Declaration of Helsinki. The study was approved by the
Institutional Review Board of the University of Iowa (IRB ID
No. 9507432). Primary human airway epithelia were isolated from
discarded and deidentified trachea and bronchi of donor lungs.
This study used discarded lung tissue, thus the IRB deemed
consent was not needed.
Materials and constructs
FLAG M2 antibody (Ab) was purchased from Sigma (F3165, St.
Louis, MO), mouse anti-CD55 (DAF) was from BD Pharmingen
(555691, San Jose, CA), mouse anti-Ezrin was from Santa Cruz
(SC-58758, Santa Cruz, CA), mouse anti-acetylated a-tubulin was
from Sigma (St. Louis, MO), Alexa-488 and -568 conjugated goat
anti-mouse or anti-rabbit Abs, mouse and rabbit anti-GFP were
from Molecular Probes (Eugene, OR). RmcB Ab (CRL-2379,
ATCC, Manassas, VA) was produced by the University of Iowa
Hybridoma Core. Rabbit anti-hCAR 1605 was produced in
rabbits immunized with a GST fusion to the intracellular c-
terminus (aa 261–365) as previously described [40]. Rabbit anti-
hCAREx7 5490 and Rabbit anti-hCAREx8 5678 were produced in
rabbits immunized with peptides of 13 c-terminal amino acids
(CVMIPAQSKDGSIV and FKYPYKTDGITVVC respectively).
COS-7 cells were from ATCC (Manassas, VA), and maintained
under standard culture conditions (D-MEM with 10% FCS,
penicillin and streptomycin). CHO-K1 cells were from BD
Biosciences (Franklin Lakes, NJ) and maintained under standard
culture conditions (D-MEM with 10% FCS, supplemented with
tetracycline L-glutamine, penicillin and streptomycin). Ad serotype
5 containing the b-galactosidase (Ad-bGal), eGFP, RFP (peGFP-
N1, pDSRed1, Clontech, Palo Alto, CA), or hCAR gene have
previously been described [41,42]. The University of Iowa Gene
Transfer Vector Core produced all viruses. Several cDNAs were
kind gifts from the following investigators: hCAR was from Ronald
Crystal; peGFP-MAGI-1b was from Irina Dobrosotskaya; PSD-
95-GFP was from David Bredt. The cDNA for PICK1-GFP has
previously been described [43] and MAGI-1b-CMV-myc was
subcloned and contained aa 642-1287.
Web programs
We performed a BLAT search with the mouse sequence (www.
genome.ucsc.edu) to determine the human sequence for exon 8.
Comparison of hCAR P343 to mCAR A343 using Conseq
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software identified this amino acid as an exposed or buried residue
respectively with a non-structural role. Conservation could not be
determined due to insufficient data. The score assigned by Conseq
was validated using PolyPhen (http://www.bork.embl-heidelberg.
de/polyPhen/).
Cloning of hCAREx8 and site directed mutagenesis
hCAREx8 was cloned from RNA isolated from primary human
airway epithelia (Qiagen, Valencia, CA; hCAREx8F: 59GCGAA-
TTCGCCACCATGGCGCTCCTGCTCTGCTTCG andhC-
AREx8R: 59GTGGATCCTTATACAACTGTAATTCCATC). The
fragment was digested with EcoRI and BamHI and cloned into
pcDNA3.1(-) or an Ad5-CMV shuttle plasmid. DNA sequencing and
Western blot confirmed the expected protein. hCAREx8 was modified
with two FLAG tags (DYKDDDDK) added between amino acid 22
and 23, similar to previously described modifications in hCAREx7. Site-
directed mutagenesis was performed to generate hCAREx7/8 according
to manufacturer’s standard protocol (Stratagene, Cedar Creek, TX)
with the following primer: GSIV-ITVV, 59-CCAGCACAGAG-
CAAGGATATCACTGTAGTATAGGGATCCGAGCTC.
Site-directed mutagenesis was performed to generate CAREx8/7
according to manufacturer’s standard protocol (Stratagene, Cedar
Creek, TX) with the following primer: ITVV-GSIV, 59-CCTTA-
CAAGACTGATGGAGGTTCAATTGTATAAGGATCAAG-
GGTG
Site-directed mutagenesis was performed to generate hCAREx8-PDZ
according to manufacturer’s standard protocol (Stratagene, Cedar
Creek, TX) with the following primer: ITVV-*TVV, 59-CCTTA-
CAAGACTGATGGATAAACAGTTGTATAAGGATCAAG-
GGTGG.
Human airway epithelia
Primary human airway epithelia were isolated from trachea and
bronchi of donor lungs and seeded onto collagen coated, semi-
permeable membranes (Millipore, Bedford, MA) and grown at the
air-liquid interface as previously described [44,45]. Approximately
two weeks after seeding, cultures were well-differentiated and
attained a measurable transepithelial resistance. To augment
endogenous hCAR expression, epithelia were transduced with
adenovirus carrying hCAREx7 or hCAREx8 from the basolateral
surface as previously described [23,41].
Amaxa transfection
Primary airway epithelial cells seeded on plastic were trypsin-
ized, washed and cells electroporated with 2.5 mg of plasmids
encoding hCAREx7, hCAREx8 or eGFP using the Amaxa
Nucleofector I (Amaxa Inc, Walkersville, MD) according to
manufacturer’s standard protocol for primary mammalian epithe-
lial cells (VPI-1005, program T-20). Approximately 36105 cells
were seeded onto collagen coated, semi-permeable membranes as
described above. Epithelia were infected with Ad-b-gal (MOI
10 pfu/cell) for 1 hr at 37uC, washed twice and lysed 48 hr post
infection. b-galactosidase expression per mg protein was deter-
mined as previously described [42].
Adenovirus infection
Chinese hamster ovary cells were plated in 24 well dishes and
transfected using Lipofectamine 2000 (Invitrogen, Carlsbad, CA)
following the manufacturer’s protocol. Twenty-four hours after
transfection cells were infected with Ad serotype 5 containing the
b-galactosidase gene (Ad-bGal) (MOI 100) for 1 hr at 37uC.
48 hours later cells were lysed and b-galactosidase expression per
mg protein was determined as previously described [42].
Co-transfection in COS-7 cells
COS-7 cells were electroporated by standard methodologies.
Briefly, 10 million cells were mixed with 20 mg of plasmid DNA for
single transfection, 15 mg of each DNA for double transfections, or
10 mg of each for triple transfections, in 400 ml of cytomix (120mM
KCl, 0.15mM CaCl2, 10mM K2HPO4, 10mM KH2PO4, 25mM
HEPES, 2mM EGTA, 5mM MgCl2, 2mM ATP and glutathione)
and put in an electroporation cuvette (Bio-Rad Laboratories,
Hercules, CA) for 30 minutes on ice. After electroporation, cells
were seeded onto 10cm dishes for immunoprecipitation (IP) and
collagen coated glass chamber slides for immunofluorescence
studies 2 days later.
Immunostaining
COS-7 cells grown on collagen coated chamber slides or airway
epithelia were washed once with PBS, fixed with 4% paraformal-
dehyde, permeabilized with 0.1% Triton X-100, and blocked with
2% BSA in SuperBlock (Pierce, Rockford, IL). Cells were
incubated with primary Ab, washed extensively and incubated
with goat anti-mouse Alexa-568 secondary Ab. After washing,
slides were coverslipped with Vectashield mounting media (Vector
Laboratories, Inc, Burlingame, CA). Images were acquired with a
BioRad MRC-1024 Laser Scanning Confocal Microscope (Her-
cules, CA) mounted on a Nikon E600 microscope (Melville, NY)
using a 60X oil immersion lens. Fluorescence imaging was
performed on an Olympus IX71 X-Cite 120 fluorescence
microscope (Center Valley, PA) followed by quantitation using
Image J.
Quantitative real time PCR
RNA was isolated from primary airway cultures greater than 2
weeks old or primary lung tissue using TRIzol with the Pure Link
RNA kit (Invitrogen). cDNA was synthesized using RT2 EZ First
Strand Kit (SA Biosciences). Primers and probes for the seventh or
eighth exon of CXADR were designed with Primer Express
software (Applied Biosystems). The sequences for hCAREx7 were:
hCAREx7-F, 59-TGCCAGAAGCTACATCGGCAGTAA; hCA-
REx7-R, 59-ATAGACCCATCCTTGCTCTGTGCT; hCAREx7
probe, 59-AAGTCGAATGGGTGCGATTCCTGTGA (59 FAM,
39 TAMRA-SP); PCR product 141bp. The sequences for the
hCAREx8 were: hCAREx8-F, 59-AGGGAAGATGTGCCACCTC-
CAAA; hCAREx8-R, 59-CAACTGTAATTCCATCAGTCTTG-
TAAG; hCAREx8 probe, 59-ACTGCCAGAAGCTACATCGG-
CAGTAA (59 FAM, 39 TAMRA-SP); 165bp. Samples were run
using TaqMan Fast Universal PCR Master Mix (Applied Biosystems)
on a 7500 Fast Real-Time PCR System (Applied Biosystems).
Transcript number was quantitated by plasmid standard curve.
Abundance relative to 18s (Invitrogen, 115HM-02) or hGAPDH
(Invitrogen, 100H-02) as the reference gene confirmed the presence
of significantly more hCAREx7 transcripts than hCAREx8.
Immunoprecipitation and Western blot
Cells from two 100mm plates were placed on ice, washed once
with ice cold PBS, and lysed with lysis buffer (50mM Tris-HCl,
pH 7.5, 137mM NaCl, 1% Triton X-100, 5mM EDTA, 1mM
EGTA, protease inhibitors (10 mg/ml) leupeptin, aprotinin,
pepstatin, and 1mM phenylmethylsulfonyl fluoride) by rocking at
4uC. Cells were scraped, sonicated 5 times and spun in a
microcentrifuge at full speed for 10 minutes. For co-immunopre-
cipitation, supernatant was incubated with the indicated Ab with
rotation at 4uC overnight. Protein A or G conjugated sepharose
(Amersham Biosciences, Uppsla Sweden) was added for 1-2 hours
followed by a wash with lysis buffer, 10% lysis buffer in TBS
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(50mM Tris-HCl, pH 7.5, 137mM NaCl), and TBS. Beads were
suspended in loading buffer (4% sodium dodecyl sulfate, 100mM
dithiothreitol, 20% glycerol, 65mM Tris, pH 6.8, 0.005%
bromophenol blue) and proteins were separated by SDS-poly
acrylamide gel electrophoresis. Gels were transferred to a
polyvinylidene difluoride membrane (Millipore, Bedford, MA),
blocked with 5% BSA, washed, probed with primary Ab as
indicated, followed by washing and incubation with protein A or
G conjugated HRP (Pierce, Rockford, IL). Bands were detected
with ECL reagents (Pierce, Rockford, IL) and imaged on the
EpiChemi3 Darkroom (UVP Inc, Upland, CA).
Supporting Information
Figure S1 Endogenously expressed CAREx8 (A, D, G) in
polarized human airway epithelia localizes above ZO-1 (B, C) and
co-localizes with the apical protein ezrin (E, F, G). Sections are
shown in X-Y (A-F) or X-Z (G) axes. Confocal microscopy (60x oil
immersion).
Found at: doi:10.1371/journal.pone.0009909.s001 (9.08 MB TIF)
Figure S2 Quantitative RT-PCR primers for CAREx7 or
CAREx8 are specific. Primary airway were either mock
transduced or transduced with adenovirus carrying the gene for
CAREx7 or CAREx8. RNA was isolated 36 hours later and
subjected to isoform specific quantitative RT-PCR. Under mock
conditions there was more endogenous CAREx7 than CAREx8.
Epithelia transduced with CAREx7 or CAREx8 showed increased
trascript levels but did not increase transcript levels of the other
isoform.
Found at: doi:10.1371/journal.pone.0009909.s002 (2.91 MB TIF)
Figure S3 Expression of exogenous CAREx8 in polarized
human airway epithelia mediates five-fold greater Ad-b-Gal gene
transfer than endogenous expression (mock transduced cells
followed by Ad-b-Gal). *p,0.0001 Ad-CAREx8 vs. Mock/Ad-
b-Gal or Mock/no virus. p = 0.03 Mock/Ad-b-Gal vs. Mock/no
virus.
Found at: doi:10.1371/journal.pone.0009909.s003 (2.50 MB TIF)
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